Ardelyx Inc Company Profile
What is the competitive landscape for ARDELYX INC
ARDELYX INC has two approved drugs.
There are eight US patents protecting ARDELYX INC drugs.
Drugs and US Patents for Ardelyx Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ardelyx Inc | XPHOZAH | tenapanor hydrochloride | TABLET;ORAL | 213931-001 | Oct 17, 2023 | DISCN | Yes | No | 12,016,856 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Ardelyx Inc | XPHOZAH | tenapanor hydrochloride | TABLET;ORAL | 213931-002 | Oct 17, 2023 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Ardelyx Inc | IBSRELA | tenapanor hydrochloride | TABLET;ORAL | 211801-001 | Sep 12, 2019 | RX | Yes | Yes | 8,969,377 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Ardelyx Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 5805802 | ⤷ Start Trial |
| Mexico | 2015014351 | ⤷ Start Trial |
| Poland | 2983667 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

